A recent editorial published in Nature Magazine calls on researchers to stay updated and explore and validate innovative alternatives. “𝐼 𝑚𝑒𝑛𝑡𝑖𝑜𝑛 𝑖𝑡, 𝑎𝑛𝑑 𝑡ℎ𝑒𝑦 𝑙𝑜𝑜𝑘 𝑎𝑡 𝑚𝑒 𝑙𝑖𝑘𝑒 𝐼 𝑓𝑒𝑙𝑙 𝑓𝑟𝑜𝑚 𝑡ℎ𝑒 𝑠𝑘𝑦” This is a common response that Ofer Levy, a vaccinologist at Boston Children´s Hospital, receives when talking about the 2022 groundbreaking law allowing researchers to test drug candidates on human tissue or computer models before First in Human trials. Levy has long advocated that studies in human tissue, in some cases, can be more informative than those done on animals. He says, “They still make use of animal models — just 70–80% less than the average research group”. This change challenges long-standing practices and offers numerous benefits. •𝐈𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐀𝐜𝐜𝐮𝐫𝐚𝐜𝐲: Studies in human tissue can provide more relevant data than those in animal models, particularly in fields like immunology, where differences between species can give misleading results. •𝐄𝐭𝐡𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞𝐬: Reducing reliance on animal testing addresses ethical concerns and emotional burdens associated with animal research. What do you think are the requirements to implement these technologies in your drug development? Discussing this matter is crucial for advancing the drug development process! Feel free to share and join the discussion. Find the full editorial piece here: https://lnkd.in/daM5czXb Learn more about how Immuneed approaches this challenge here: https://lnkd.in/ds3P4DtR #InnovationInResearch #EthicalResearch #AnimalTestingAlternatives #DrugDevelopment #ResearchTechnology
Immuneed
Forskning
Select the most promising drug candidates with us and accelerate your path to drug development.
Om oss
Our technology, ID.Flow, utilizes freshly donated human blood to help researchers better understand drug-induced immune reactions during non-clinical development. By improving the accuracy and relevance of safety and efficacy assessments, we reduce the need for animal studies and enhance the translatability of preclinical findings.
- Webbplats
-
https://www.immuneed.com
Extern länk för Immuneed
- Bransch
- Forskning
- Företagsstorlek
- 11–50 anställda
- Huvudkontor
- Uppsala
- Typ
- Privatägt företag
- Grundat
- 2014
- Specialistområden
- Immunotoxicity, Drug development, Monoclonal antibodies, Immune complexes, Contract research organization, Cytokine Release Assay, Safety Assessment, MoA, Functional studies, Biologics, Proteins, Peptides, Small molecules, Complement Activation, Innate Immunity, In-Vitro Immunotoxicity, Immune profiling, Immuno-oncology, Platelet activation, Monocyte activation, ADCC & CDC assays och non-clinical
Adresser
-
Primär
Uppsala
Uppsala, SE
Anställda på Immuneed
Uppdateringar
-
🌟 Celebrating Our GLP Certification Renewal! 🌟 Immuneed is proud to announce the successful renewal of our Good Laboratory Practice (GLP) certification, reaffirming our commitment to top-notch quality and reliability. This achievement is a testament to our team’s hard work and dedication and further strengthens our promise to deliver outstanding services, adhering to the highest industry standards. In the words of our Test Facility Manager, Gunilla Törnqvist, “We are very proud of this achievement as it showcases our organization's strategic commitment to quality and meeting customer and regulatory expectations.” Thank you to everyone involved for your dedication! #GoodLaboratoryPractice #QualityFirst #ContinuousImprovement #TeamSuccess
-
🌟 New Blog Alert: Exploring the Complement System: A Double-Edged Sword in Drug Development 🌟 🔍 From aiding in identifying promising drug candidates through its pathogen-clearing capabilities to the challenges of avoiding unintended activation during drug development, this blog covers essential ground. Whether you're involved in pharmaceuticals, biotech, or just fascinated by the intersection of immunology and drug development, this piece offers interesting perspectives on navigating the complement system's complexities. 🔗 Read the full blog here: https://lnkd.in/d2P5ac49 #Immunology #DrugDevelopment #ComplementSystem #PharmaceuticalInnovation
-
We are excited to share that Helena Laven has started her new role as Scientific Advisor at Immuneed Describe your journey with Immuneed. I moved to Uppsala from the US in 2021, attracted by the area's thriving biotechnology industry. With a background in immunology, I was excited about Immuneed's potential to impact human health. I started as a lab analyst, specializing in FACS cell analysis, and have advanced to a Scientific Advisor role now in 2024, contributing to innovative immunological research What are you most looking forward to in your new role? One of my key strengths is problem-solving. I really look forward to designing ways to help customers address their questions using our test system. What do you do when you're not working? One of my favourite activities is spending time in the Swedish wilderness, and I’ve been able to explore some really amazing places together with my family. I also enjoy less strenuous activities like reading and knitting. To meet one of our Scientific Advisors, make sure to connect with us here: https://lnkd.in/d73N_vnt
-
🎉Celebrating 10 incredible years🌟 Reflecting on memorable moments and key achievements that have defined our journey. Thank you for being an integral part of the Immuneed journey. https://immuneed.com/
-
The act of donating blood helps save lives and brings hope to those in need. Whether it's for medical emergencies, life-saving treatments, or groundbreaking research, your contribution makes a profound difference. #worldblooddonorday #donateblood
-
Immuneed omdelade detta
Time for #metatrends Europe must not miss w European Investment Fund (EIF) #bebold #30yearsbold #science #futureofmedicine #growbig Immuneed Strike Pharma AB #precisionmedicine #immunotherapy #cure #prevention #sustainable #healthcare
-
Leveraging his expertise from the European Medicines Agency (EMA), Immuneed's Director of Business Science Wing Cheng shares invaluable insights into antisense oligonucleotides (ASOs). In this exclusive interview, he delves into the nonclinical strategies and the inherent value of ASOs in treating genetic and rare diseases. 💡Learn more about: -The mechanism and functionality of ASOs. -Unique advantages of ASOs over other therapeutic agents. -Key applications of ASOs in genetic disorders and cancer treatment. -Challenges and recent advancements in ASO research. -The role of ASOs in personalized medicine and targeted therapies. -Strategies for preclinical development and navigating regulatory pathways. Read the full interview on our blog now! https://lnkd.in/d-BaxCu3 #antisenseoligonucleotides
-
Immuneed omdelade detta
Oj jag fick vara med i sjukvårdspodden 🤗😎🙌 svåra ämnen, men så viktiga! Tack Magnus Lejelöv för att du ledde mig igenom samtalet och för de tankar du väcker genom detta samtal. Vi har mycket att göra framåt för att samla hela vårt lands potential och skapa hållbar och innovativ sjukvård 🙏💉 #podd #sjukvård #innovation #uppsala Farmaceutiska fakulteten • Uppsala universitet Uppsala University Region Uppsala Uppsala kommun SLU - Swedish University of Agricultural Sciences Strike Pharma AB Immuneed
Idag släpps ett nytt avsnitt av hälso- och sjukvårdspodden från Forum för Health Policy där jag samtalar med Sara Mangsbo från Uppsala universitet, SLU - Sveriges lantbruksuniversitet, Immuneed, Strike Pharma AB och med en massa andra hattar! Vi pratar om forskning och innovation och hur det hänger ihop med hälso- och sjukvården i övrigt! Vi pratar drivkrafter, priser och en massa annat. Och till extra glädje för Björn Arvidsson, Kristofer Klerfalk, OLLE BERGDAHL m.fl. pratar vi en del om Uppsala också! Ett fint samtal som så ofta i denna podd säger jag klart oödmjukt… https://lnkd.in/dPTVwgXG
Hälso- och sjukvårdspodden: Vi samtalar med Sara Magnsbo i Apple Podcasts
podcasts.apple.com
-
We're delighted to announce that our valued colleague, Wing Cheng, has been recognized by Connect Sverige Region Uppsala for his exceptional warmth, competence, and subject matter expertise💡. This well-deserved recognition is a testament to Wing´s dedication and contribution to our team and beyond, Congratulations!
Board Member | Director | Senior Advisor | Pricing & Market Access | Life Science Strategy | Angel Investor
🎶🎶 Oh, vilken härlig (Connect) dag!🎶🎶 🙏Jag vill rikta ett hjärtligt tack till för den ärofyllda utmärkelsen som ”Årets engagemang” på Connectdagen!! Jag känner mig överväldigad och djupt tacksam för denna uppskattning från företag, investerare och mina kollegor på Connect.🤩 🍀Att få vara en del av det fantastiska investerarnätverket här i Uppsala och kunna bidra med min tid, expertis och nätverk är något som jag värdesätter mycket högt och ger mig stor glädje. Det är en ära att vara en del av denna gemenskap. 🤝 🙏Jag vill särskilt tacka Connect Sverige Region Uppsala för att ni skapar en dynamisk miljö där tillväxt och investeringar blandas med hjärta och gemenskap. Ni gör verkligen skillnad! 🤩 🌟Dagen var på alla sätt helt magisk där jag även fick möjlighet att pitcha för mina fina bolag Immuneed och Phenaros Pharmaceuticals som grädden på moset! 🚀 Än en gång, tack för detta värdefulla erkännande!
Liknande sidor
Finansiering
Senaste finansieringsrunda
Kapital504 292,00 US$
Investerare
Almi Invest